Literature DB >> 10507253

Role of microbial burden in aetiology of allergy and asthma.

F D Martinez1, P G Holt.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10507253     DOI： 10.1016/s0140-6736(99)90437-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  70 in total

Review 1.  Science, medicine, and the future. Allergic disorders.

Authors:  S T Holgate
Journal:  BMJ       Date:  2000-01-22

2.  Age at childhood infections and risk of atopy.

Authors:  P Bager; T Westergaard; K Rostgaard; H Hjalgrim; M Melbye
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

Review 3.  The bifidobacterial and Lactobacillus microflora of humans.

Authors:  Gerald W Tannock
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

Review 4.  Vaccination strategies to reduce the risk of leukaemia and melanoma.

Authors:  John M Grange; John L Stanford; Cynthia A Stanford; Klaus F Kölmel
Journal:  J R Soc Med       Date:  2003-08       Impact factor: 5.344

5.  Indoor allergens, asthma, and asthma-related symptoms among adolescents in Wuhan, China.

Authors:  Päivi M Salo; Jiang Xia; C Anderson Johnson; Yan Li; Edward L Avol; Jie Gong; Stephanie J London
Journal:  Ann Epidemiol       Date:  2004-09       Impact factor: 3.797

6.  Infections, medication use, and the prevalence of symptoms of asthma, rhinitis, and eczema in childhood.

Authors:  Catherine Cohet; Soo Cheng; Claire MacDonald; Michael Baker; Sunia Foliaki; Nyk Huntington; Jeroen Douwes; Neil Pearce
Journal:  J Epidemiol Community Health       Date:  2004-10       Impact factor: 3.710

7.  Investigating indicators and determinants of asthma in young adults.

Authors:  Mario Grassi; Massimiliano Bugiani; Roberto de Marco
Journal:  Eur J Epidemiol       Date:  2006-11-22       Impact factor: 8.082

Review 8.  Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders.

Authors:  M Goldman
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 9.  Life course health development: an integrated framework for developing health, policy, and research.

Authors:  Neal Halfon; Miles Hochstein
Journal:  Milbank Q       Date:  2002       Impact factor: 4.911

10.  Inhibition of experimental asthma by indoleamine 2,3-dioxygenase.

Authors:  Tomoko Hayashi; Lucinda Beck; Cyprian Rossetto; Xing Gong; Osamu Takikawa; Kenji Takabayashi; David H Broide; Dennis A Carson; Eyal Raz
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.